Test Price
2,800 AED✅ Home Collection Available
DCXR Gene Pentosuria NGS Genetic Test in Dubai
Executive Summary & Core Metrics
- Diagnostic Precision: 99.9% analytical sensitivity via ISO 15189‑accredited NGS processing on Illumina NovaSeq, exceeding DHA clinical validity benchmarks.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM) by DHA‑licensed nurses – no clinic visit required.
- Post‑Test Clinical Guidance: Telephonic interpretation session with a Consultant Medical Geneticist, translating raw NGS data into actionable health insights.
- Insurance & Billing: Instant direct‑billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The DCXR Gene Pentosuria NGS test detects pathogenic variants in the DCXR gene, confirming a diagnosis of essential pentosuria – a benign but under‑recognised metabolic anomaly characterised by persistent urinary pentose excretion. In the UAE, this ISO‑backed analysis empowers individuals, general physicians, and researchers with definitive genetic evidence for personalised carbohydrate metabolism management.
| Feature | Our DCXR NGS Test | Closest Alternative (PCR‑based) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq) | Targeted PCR + Sanger confirmation |
| Variant Coverage | Full gene (>95% of coding regions, CNV detection) | Pre‑defined hotspot exons only |
| Turnaround Time | 15‑18 business days (with statutory UAE quality review) | 7‑10 business days (limited scope) |
| Price (AED) | 2800 | 1800‑2200 |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist with extensive experience in hereditary metabolic disorders, I view the DCXR NGS test as a precise tool that must always be interpreted alongside clinical context. A positive result confirms essential pentosuria, a benign condition that does not require aggressive intervention, while a negative result may necessitate exploration of other carbohydrate‑metabolism disorders. I urge every patient to discuss the implications with a qualified specialist before and after testing.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory Notice – Medication & Lifestyle
Do not discontinue any prescribed medication or alter your carbohydrate intake based solely on this test result. Always consult your supervising physician before making therapeutic changes.
Patient Safety & Exclusion Criteria
Exclusion Criteria for Home Collection
- Known severe bleeding diathesis (e.g., haemophilia) – requires hospital‑based venipuncture.
- Active febrile illness or acute infection that may technically compromise DNA extraction from whole blood.
- Inability to provide informed consent (mental incapacity without a legal guardian).
ER Red Flags – Seek Immediate Medical Attention
- New‑onset symptoms of metabolic crisis: unexplained hypoglycaemia, vomiting, or lethargy – do not wait for test results.
- Severe allergic reaction (anaphylaxis) during or after sample collection.
- Sudden confusion or loss of consciousness in the patient.
Patient FAQ & Clinical Guidance
1. What is the DCXR gene pentosuria test and who should consider it in the UAE?
The DCXR gene pentosuria test is a next‑generation sequencing analysis that identifies genetic variants causing essential pentosuria, a benign hereditary disorder of carbohydrate metabolism. It is especially valuable for UAE residents with persistent urinary pentose excretion, family history of unexplained carbohydrate anomalies, or for pre‑conception genetic counselling, supported by DHA‑approved laboratories.
2. How accurate is the NGS methodology and what does the turnaround time mean for clinical decisions?
NGS achieves 99.9% analytical sensitivity for single nucleotide variants and small indels, making it the gold‑standard for detecting DCXR mutations. The 15‑18 business‑day turnaround under UAE statutory review ensures your report is cross‑validated by two clinical molecular geneticists, providing reliable data for definitive dietary and lifestyle recommendations.
3. Is this test covered by UAE health insurance and how do I arrange home collection?
Direct billing verification is conveniently provided: simply WhatsApp your Emirates ID and insurance card to +971 54 548 8731 for instant confirmation of coverage. Once approved, a DHA‑licensed phlebotomist will visit your home or office (8 AM‑11 PM) – the service includes all transport media and cold‑chain logistics at no extra cost.
4. What pre‑test requirements must I fulfil before sample collection?
You must provide a detailed clinical history including prior metabolic work‑up and a symptom diary. A pre‑test genetic counselling session will be conducted to draw a pedigree chart of family members affected with pentosuria. For minors under 18, a legally authorised parent or guardian must provide signed informed consent as mandated by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
UAE Regulatory & Data Privacy Adherence
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL): Your genomic data is processed, stored, and anonymised strictly within the UAE. It is never shared with third parties without explicit, time‑bound consent; rights to data rectification and erasure are fully maintained.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: All electronic health records and genetic data transmissions comply with UAE federal standards for cybersecurity and health information exchange.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability: Clinical testing safety and patient consent procedures follow this governing framework, ensuring full legal protection for patients undergoing genetic analysis.
- ISO 15189:2022 & ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139): End‑to‑end quality management – from sample accession to bioinformatics pipeline – is audited annually by an EU‑accredited body under the Dubai Health Authority licensing framework.
Clinical & Logistical Metadata
| Test Name | DCXR Gene Pentosuria Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 15–18 Business Days |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (Illumina NovaSeq) with Full Gene Coverage & CNV Detection |
| ICD-10-CM Code | E74.8 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians